Global Genes™ Appoints New COO, VP of Patient Advocacy and VP of Strategic Alliances
Research and Markets: Top 50 Big Biotech Partnering and M&A Deal Trends Report 2015
Health-care stocks are on a tear as demand slowly returns.
The five biotech ETFs have very different portfolios with markedly different performance.
While we remain bullish on the sector, health-care growth depends on the economy.
With two years of stellar returns behind us, our expectations for 2013 are more muted, but some opportunities persist.